Eric Careau, Ph.D, MBA, CAAM

Eric careau, ph.d, mba, caam

bookmark on deepenrich
location of Eric Careau, Ph.D, MBA, CAAMBasel, Basel, Switzerland
Followers of Eric Careau, Ph.D, MBA, CAAM860 followers
  • Timeline

  • About me

    Director Global Divestment & Outlicensing at Novartis

  • Education

    • Université laval

      2002 - 2005
      Mba pharmaceutical management
    • Université laval

      2001 - 2005
      Phd microbiology/immunology
  • Experience

    • Becton dickinson, geneohm

      Jun 1999 - Apr 2007

      Project management of an international R&D molecular diagnostic project. Lead creation of Business plan, Competition Analysis, Product Definition, and Study Protocol by identifying and working closely with Industry KOLs and upper management. Responsible for blood bank products analysis and for leading stability testing and reporting. (Part-time position)

      • Associate Project Leader

        May 2005 - Apr 2007
      • Lab Technician, Quality Control

        Jun 1999 - May 2005
    • Aeterna zentaris inc.

      Nov 2007 - Oct 2010
      Manager clinical trial medication and r&d project manager

      Responsible to develop an international clinical supply chain network to distribute study medication in over 120 clinical sites spread over 15 countries. Manage CMOs in production and distribution of clinical trial medication for Phase I to III studies and to assist the VP R&D in management of departmental and contractual timelines.

    • Novartis animal health

      Apr 2010 - May 2012
      Global portfolio manager

      Manage value, costs, risk, timing and attrition of the Global R&D project portfolio in close collaboration with Marketing and R&D. Manage generation of insights about the pipeline to support decision making by senior management bodies and to propose resource allocation options.

    • Elanco

      May 2012 - Apr 2015
      Global alliance manager, commercial

      Lead commercial alliances implementation and coordinate new products launch preparation. Responsible for creating value by ensuring the smooth functioning of the commercial alliances, by being part of deal making process, by deeply understanding the partner’s situation, and by being able to anticipate/avoid problems/issues.

    • Novartis

      May 2015 - now

      Work in close relationship with partners to implement and coordinate out-licencing and divestment projects.

      • Director Global Divestment & Out-licensing

        Jan 2021 - now
      • Head BD&L Project and Alliance Management, EM

        May 2018 - Jan 2021
      • Senior BD&L Project and Alliance Manager

        May 2015 - Apr 2018
  • Licenses & Certifications

    • Certification of achievement–alliance management (ca-am)

      The association of strategic alliance professionals
      Nov 2012
      View certificate certificate